Immunoassay Market will reach USD 19.76 billion by 2025: Meticulous Research®

Immunoassay Market by Product (Kits and Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025.

pune, India - January 15, 2020 /MarketersMedia/ —

Immunoassays are used in healthcare industry in various diagnostic applications, including infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, and neonatal screening. Increasing incidence of chronic and infectious diseases, growing use of immunoassay in oncology, and rise in drug and alcohol testing are expected to drive the immunoassay market during the forecast period. Furthermore, immunoassay diagnostics are gaining higher attention from end users owing to its several advantages such as, high sensitivity, lower testing time, low limits of detection, high-throughput diagnosis, and inexpensive method. Subsequently, growing technological advancements in immunoassay are further expected to fuel the growth of immunoassay market over the coming years. Meticulous Research® in its latest publication on Immunoassay Market reveals that the global immunoassay market will increase at a CAGR of 5.9% from 2019 to 2025 to reach $19.76 billion by 2025.

The increase in the outbreaks of infectious diseases worldwide, and emerging economies such as Latin America, South East Asia, and Africa provides significant growth opportunities to the manufacturers operating in the global immunoassay market. However, limitations of immunoassays and development of alternative technologies are some of the key factors that may hinder the adoption of immunoassay products.

Get Free Sample Copy of Immunoassay Market Report at:

To provide efficient analysis, Meticulous Research® has segmented this market on the basis of product (immunoassay kits & reagents, immunoassay analyzers, immunoassay software & services), platforms (chemiluminescence immunoassays, fluorescence immunoassays, colorimetric immunoassays, radioimmunoassays, other platforms) application (infectious diseases, cardiology, endocrinology, oncology, bone & mineral disorders, autoimmune disorders, allergy, other applications), end user (hospitals & clinics, clinical laboratories/reference labs, blood banks, pharmaceutical and biotechnology companies, research & academic laboratories, other end users), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

In 2018, infectious diseases segment accounted for the largest share of the global immunoassay market, by application. The largest share of this segment is mainly attributed to rising incidence of infectious diseases and growing adoption of immunoassay diagnostics in the management of infectious diseases.

Geographic Review
Geographically, North America commanded the largest share in this market followed by Europe. Asia Pacific region is expected to grow at the higher CAGR during the forecast period. The immunoassays market in Asia Pacific region, especially in China and India, is expected to witness high growth during the forecast period. Growth in this market is expected to be driven by large pool of patient population, increasing prevalence of infectious diseases and cancer, increasing government spending on the healthcare, and improving accessibility to diagnosis and treatment services. In addition, favorable government policies and healthcare structural reform are further expected to drive the market growth.

Immunoassay Market Key Players:
The report provides competitive intelligence in terms of company overview, financials, growth strategies, product benchmarking, geographical presence, and market share analysis on some of the key market players including F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SPA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Quidel Corporation (U.S.), Bio-Techne Corporation (U.S.), and Mindray (China) among others.

Technological Advancements in Immunoassay
Immunoassays have been one of the fast-growing clinical diagnostics technologies over the years. The technological advancements in immunoassays driven by the need for early detection of diseases have supported their adoption over the years, and hence have supported the immunoassay market growth. Today, with the development of excellent methods of signal generation, the attention has shifted to the development of immunochemical methods and instruments to provide convenient high-performance systems. Important advances have been made in the design of immunochemical approaches that allow small molecules, such as drugs, metabolites and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages previously seen only with large molecular analytes. Bispecific antibodies and recombinant proteins are also beginning to provide an impact upon immunodiagnostics, with the promise of reagents which are even more particular. Through all these advances, the usage of immunoassays is further expected to expand, in turn supporting the market growth.

Browse Full Research Report with TOC at:

Table Of Contents
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
3.1. Introduction
3.2. Market Dynamics
3.3. Product Segment Analysis
3.4. Platforms Segment Analysis
3.5. Application Analysis
3.6. End User Analysis
3.7. Regional Analysis
3.8. Competitive Analysis

4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Incidence of Chronic Diseases and Infectious Diseases
4.2.2. Increasing Use of Immunoassays in Oncology
4.2.3. Vital Role of Immunoassays in Drug and Alcohol Testing
4.2.4. Technological Advancements in Immunoassay
4.3. Restraints
4.3.1. Limitations of Immunoassay
4.4. Opportunities
4.4.1. Growth Opportunities in Emerging Economies
4.4.2. Increasing Epidemic Potentials

5. Global Immunoassay Market, by Product
5.1. Overview
5.2. Immunoassay Kits and Reagents
5.2.1. Rapid Test Kits and Reagents
5.2.2. Elisa Kits and Reagents
5.2.3. Western Blot Kits and Reagents
5.2.4. Elispot Kits and Reagents
5.2.5. Other Immunoassay Kits and Reagents
5.3. Immunoassay Analyzers
5.4. Immunoassay Software and Services

6. Global Immunoassay Market, by Platforms
6.1. Overview
6.2. Chemiluminescence Immunoassays
6.3. Fluorescence Immunoassays
6.4. Colorimetric Immunoassays
6.5. Radioimmunoassays
6.6. Other Immunoassay Platforms

7. Global Immunoassay Market, by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Cardiology
7.4. Endocrinology
7.5. Oncology
7.6. Bone and Mineral Diseases
7.7. Autoimmune Disease
7.8. Allergy
7.9. Other Applications

8. Global Immunoassay Market, by End User
8.1. Overview
8.2. Hospitals and Clinics
8.3. Clinical Laboratories
8.4. Blood Banks
8.5. Pharmaceutical and Biotechnology Companies
8.6. Academic & Research Institutions
8.7. Other End Users
Click Here to Get Complete TOC

To Purchase This Report, Click here:

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Research®
Address: Pune, India
Phone: +91 744-7780008

Source URL:

Source: MarketersMedia

Release ID: 88942756

Latest News

Soleimani, a general who became Iran icon by targeting US

Aug 3, 2020

TEHRAN, Iran — For Iranians whose icons since the Islamic Revolution have been stern-faced clergy, Maj. Gen. Qassem Soleimani widely represented a figure of national resilience in the face of four decades of U.S. pressure. For the U.S. and Israel, he was a shadowy figure in command of Iran's proxy forces, responsible for fighters in Syria backing President Bashar Assad and for the deaths of American troops in Iraq. Solemani survived the horror of Iran’s long war in the 1980s with Iraq to take control of the Revolutionary Guard’s elite Quds Force, responsible for the Islamic Republic’s foreign campaigns. Relatively...

Muslim hajj pilgrims ascend Mount Arafat for day of worship

Aug 3, 2020

MOUNT ARAFAT, Saudi Arabia — More than 2 million Muslims are gathered at the sacred hill of Mount Arafat in Saudi Arabia for an intense day of worship and reflection on what's considered the climax of the Islamic hajj pilgrimage. Some had tears streaming down their faces as the men, wearing simple white garments, and women raised their hands in worship on the slopes of the rocky hill. Many walked through the pre-dawn darkness early Saturday to the hill where the Prophet Muhammad delivered his final sermon some 1,400 years ago, calling for equality and unity among Muslims. One of...

Saudi changes allow women to travel without male consent

Aug 3, 2020

DUBAI, United Arab Emirates — Saudi Arabia published new laws early Friday that loosen restrictions on women by allowing any citizen to apply for a passport and travel freely, ending a long-standing guardianship policy that gave men control over women. The changes are a potential game-changer for Saudi women's rights in the kingdom. The legal system has long been criticized because it treated women as minors throughout their adult lives, requiring they have a man's consent to obtain a passport or travel abroad. Often a woman's male guardian is her father or husband, and in some cases a woman's own...

The Latest: UN chief calls for 'maximum restraint' in Gulf

Aug 3, 2020

DUBAI, United Arab Emirates — The Latest on the tensions between the United States and Iran (all times local): 10:45 p.m. U.N. Secretary-General Antonio Guterres is again calling for "maximum restraint" in the Persian Gulf region and warning all parties that a new confrontation "would be a catastrophe." U.N. deputy spokesman Farhan Haq reiterated the U.N. chief's plea to avoid any escalation when asked Thursday for Guterres' reaction to Britain saying Iranian vessels tried to block one of its oil tankers in the Gulf. Haq said the U.N. hopes all nations "will take steps to avoid" an escalation and confrontation....

Egypt demands Christie's halt auction of King Tut statue

Aug 3, 2020

CAIRO — Egypt has tried to halt the auction of a 3,000-year-old stone sculpture of the famed boy pharaoh Tutankhamun at Christie's in London, while the auction house said its sale was legal. The statue — a brown quartzite head depicting King Tut — is scheduled to be auctioned off in July, and could generate more than $5 million, according to Christie's. The artifact features King Tut's full mouth with slightly drooping lower lips and almond-shaped eyes. For many, King Tut is the ultimate symbol of ancient Egypt's glory. Howard Carter discovered the pharaoh's nearly intact tomb in 1922 in...

About Us

Originally founded in 2015, Voyage Times publishes articles on travel and lifestyle for travelers, leisure seekers, and culture hunters from around the world.

Contact us: sales[at]

Subscribe Now!

Quick Links